Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression

Human Pathology

Volumn 43, Issue 11, 2012, Pages 1910-1916

  Adler, David ^a   Braun, Martin ^a   Nikolov, Pavel ^a   Boehm, Diana ^a   Scheble, Veit ^b   Menon, Roopika ^a   Fend, Falko ^b   Kristiansen, Glen ^a   Perner, Sven ^a   Wernert, Nicolas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

ELK 4; ETV 1; ETV 4; ETV 5; Prostate cancer

Indexed keywords

ETV 1 PROTEIN; ETV 4 PROTEIN; ETV 5 PROTEIN; TRANSCRIPTION FACTOR ELK 4; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; DISTANT METASTASIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FREQUENCY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; TISSUE MICROARRAY;

EID: 84867871081     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.01.018     Document Type: Article

References (35)

1. T. Oikawa ETS transcription factors: possible targets for cancer therapy Cancer Sci 95 2004 626 633
2. Z. Shaikhibrahim, B. Langer, and A. Lindstrot Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells Oncol Rep 25 2011 1125 1129
3. S.A. Tomlins, D.R. Rhodes, and S. Perner Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
4. M.A. Rubin, C.A. Maher, and A.M. Chinnaiyan Common gene rearrangements in prostate cancer J Clin Oncol 29 2011 3659 3668
5. C. Kumar-Sinha, S.A. Tomlins, and A.M. Chinnaiyan Recurrent gene fusions in prostate cancer Nat Rev Cancer 8 2008 497 511
6. A.M. Joshua, A. Evans, and T. Van der Kwast Prostatic preneoplasia and beyond Biochim Biophys Acta 1785 2008 156 181
7. M. Braun, V.J. Scheble, and R. Menon Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer Histopathology 58 2011 1028 1036
8. B. Han, R. Mehra, and K. Suleman Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma Mod Pathol 22 2009 1176 1185
9. S.A. Tomlins, A. Bjartell, and A.M. Chinnaiyan ETS gene fusions in prostate cancer: from discovery to daily clinical practice Eur Urol 56 2009 275 286
10. C.C. Guo, J.Y. Dancer, and Y. Wang TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate Hum Pathol 42 2011 11 17
11. V.J. Scheble, M. Braun, and T. Wilbertz ERG rearrangement in small cell prostatic and lung cancer Histopathology 56 2010 937 943
12. R. Esgueva, S. Perner, and J.C. LaFargue Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort Mod Pathol 23 2010 539 546
13. D. Pflueger, D.S. Rickman, and A. Sboner N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer Neoplasia 11 2009 804 811
14. C. Sun, A. Dobi, and A. Mohamed MPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation Oncogene 27 2008 5348 5353
15. D.K. Watson, D.P. Turner, M.N. Scheiber, V.J. Findlay, and P.M. Watson ETS transcription factor expression and conversion during prostate and breast cancer progression Open Cancer J 3 2010 24 39
16. S.A. Tomlins, B. Laxman, and S.M. Dhanasekaran Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer Nature 448 2007 595 599
17. P.C. Hollenhorst, L. Paul, M.W. Ferris, and B.J. Graves The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells Genes Cancer 1 2011 1044 1052
18. B.E. Helgeson, S.A. Tomlins, and N. Shah Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer Cancer Res 68 2008 73 80
19. Y. Miyagi, T. Sasaki, and K. Fujinami ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples Mod Pathol 23 2010 1492 1498
20. K. Iljin, M. Wolf, and H. Edgren TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming Cancer Res 66 2006 10242 10246
21. D.S. Rickman, D. Pflueger, and B. Moss SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer Cancer Res 69 2009 2734 2738
22. R. Mehra, S.A. Tomlins, and R. Shen Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer Mod Pathol 20 2007 538 544
23. B. Han, R. Mehra, and S.M. Dhanasekaran A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer Cancer Res 68 2008 7629 7637
24. D. Gasi, H.A. van der Korput, and H.C. Douben Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation PLoS One 6 2011 e16332
25. R. Mehra, S.A. Tomlins, and J. Yu Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer Cancer Res 68 2008 3584 3590
26. K.G. Hermans, H.A. van der Korput, and R. van Marion Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer Cancer Res 68 2008 7541 7549
27. K.G. Hermans, A.A. Bressers, H.A. van der Korput, N.F. Dits, G. Jenster, and J. Trapman Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer Cancer Res 68 2008 3094 3098
28. S. Perner, M.A. Svensson, and R.R. Hossain ERG rearrangement metastasis patterns in locally advanced prostate cancer Urology 75 2010 762 767
29. S. Perner, F. Demichelis, and R. Beroukhim TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer Cancer Res 66 2006 8337 8341
30. S. Perner, J.M. Mosquera, and F. Demichelis TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion Am J Surg Pathol 31 2007 882 888
31. J.C. Alers, P.J. Krijtenburg, K.J. Vissers, and H. van Dekken Effect of bone decalcification procedures on DNA in situ hybridization and comparative genomic hybridization. EDTA is highly preferable to a routinely used acid decalcifier J Histochem Cytochem 47 1999 703 710
32. V.J. Scheble, M. Braun, and R. Beroukhim ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor Mod Pathol 23 2010 1061 1067
33. M.A. Svensson, C.J. LaFargue, and T.Y. MacDonald Testing mutual exclusivity of ETS rearranged prostate cancer Lab Invest 91 2010 404 412
34. I. Meiers, D.J. Waters, and D.G. Bostwick Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007 Urology 70 6 Suppl 2007 3 8
35. M. Barry, S. Perner, F. Demichelis, and M.A. Rubin TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications Urology 70 2007 630 633